Skip to main content

Find Clinical Trials

Home
Conditions
HCC - Hepatocellular Carcinoma

Clinical trial condition

HCC - Hepatocellular Carcinoma

Explore clinical trials studying HCC - Hepatocellular Carcinoma. Study availability and eligibility vary by location and protocol.

80 public trials 38 recruiting studies

Refine in advanced search Browse all conditions

HCC - Hepatocellular Carcinoma trial results

Not yet recruiting

Evaluate the Safety and Efficacy of Combination Therapy With SYS6090 Injection for Hepatocellular Carcinoma

NCT07761286

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Harbin medical university Cancer Hospital Harbin, Heilongjiang, China

View Trial Details

Not yet recruiting

A Study of IMM2510 + IMM27M Combination Therapy in Patients With Advanced Hepatocellular Carcinoma

NCT07687914

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

SBRT Plus QL1706 as Second-Line Therapy for Hepatocellular Carcinoma

NCT07668570

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Multicenter, Randomized, Open-label, Controlled Study of HAIC Combined With Camrelizumab and Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma With High-risk Recurrence Factors

NCT07618546

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

The DoHAICs Study Expansion Phase

NCT07584018

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

Social Determinants of Health HCC Trial

NCT07568457

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Keck Hospital of USC Los Angeles, California, United States

LA General Medical Center Los Angeles, California, United States

USC Norris Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Not yet recruiting

A Clinical Trial of Firsekibart, Tislelizumab, and Lenvatinib in Patients With Unresectable, TP53-Mutated Hepatocellular Carcinoma

NCT07535840

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations: Not specified

View Trial Details

Not yet recruiting

Neoadjuvant Tislelizumab-Lenvatinib vs Surgery Alone in Stage Ia HCC With Narrow Margin

NCT07518706

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Prospective, Single-Arm, Exploratory Study of the Safety and Efficacy of Neoadjuvant Treatment With QL1706, an Anti-PD-1/Anti-CTLA-4 Bispecific Antibody, in Resectable Stage IB and IIA Hepatocellular Carcinoma With High Recurrence Risk

NCT07515469

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
Locations: Not specified

View Trial Details

Not yet recruiting

Lenvatinib and Pembrolizumab With or Without BCAA in Unresectable HCC

NCT07412054

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Not specified

View Trial Details